Sentences with phrase «new embryonic stem»

Not surprisingly, President Obama received high marks from the journal, largely because his response to the question of whether he would lift Bush's ban on the federal funding of new embryonic stem - cell lines is in line with the view of most in the scientific community.

In all likelihood, soon after he is sworn in, federal dollars will start flowing toward research on new embryonic stem - cell lines, bringing with it new battles to fight.

Not exact matches

Benedict argued that non-conjugal reproduction such as in vitro fertilization had created «new problems» ¯ the freezing of human embryos, for instance, and the selective abortion of medically implanted embryos, together with pre-implantation diagnosis, embryonic stem - cell research, and attempts at human cloning.

Two new papers have just been published documenting further advances with induced pluripotent stem cells --- stem cells that are «embryonic - like» but that are not derived from embryos.

Scientists looking for new methods to make human tissue have successfully used cloning technology to create embryonic stem cells from skin cells.

Just before Thanksgiving, news broke about a new stem - cell technique that could produce the equivalent of embryonic stem cells (ESCs) but without using or destroying human embryos.

The increasing use of in - vitro - fertilisation techniques, and the emergence of new possibilities involving human cloning, mixing of human and animal genetic elements, and the use of embryonic stem cells for research, among other things, brought the need for further teaching.

It made the front page of the New York Times, but don't let that dissuade you ¯ reports today about new ethical sources of embryonic - type stem cells are credible, and they are very good neNew York Times, but don't let that dissuade you ¯ reports today about new ethical sources of embryonic - type stem cells are credible, and they are very good nenew ethical sources of embryonic - type stem cells are credible, and they are very good news.

The year's most prominent science issue, federal support of embryonic stem cell research, is so controversial that the sons of Ronald Reagan gave dueling speeches at the opposing party conventions; Michael Reagan backs President George W. Bush's policies, including the ban on funding for research on new stem cell lines, while Ron supports Senator John Kerry's promise to lift restrictions.

«We're now developing a new bioreactor to make considerably more, which means we can make thousands and thousands more stem cells than are available from embryonic sources,» says McGuckin.

The induced pluripotent stem cells (iPSCs) that the new method produces have the same ability as embryonic stem cells to turn into any kind of tissue.

Now, many research advocates are wondering how Price's mix of views might play out in the new administration's approach to a wide range of issues, including funding, research involving human embryonic stem cells and fetal tissue, and the appointment of a new NIH director.

In May 2005, Hwang and his colleagues reported that it had produced 11 new human embryonic stem (ES) cell lines that carried the genetic signature of patients with diabetes, spinal cord injury, or a genetic blood disorder (Science, 20 May, p. 1096).

Is a new clinical trial with embryonic stem cells the breakthrough the field has been waiting for?

The laboratory process, described in the journal Scientific Reports, entails genetically modifying a line of human embryonic stem cells to become fluorescent upon their differentiation to retinal ganglion cells, and then using that cell line for development of new differentiation methods and characterization of the resulting cells.

The disease model, described in a new study by a UC San Francisco - led team, involves taking skin cells from patients with the bone disease, reprogramming them in a lab dish to their embryonic state, and deriving stem cells from them.

In 2001, after President Bush limited federally funded research to 69 existing embryonic stem cell lines, Melton launched a private fund - raising crusade and developed 17 new lines that are now available to any reputable stem cell researcher.

Our new findings tell us that low oxygen conditions actually encourage certain cancer stem cells to multiply through the same mechanism used by embryonic stem cells.»

TOKYO — Research involving human embryonic stem (ES) cells will become easier in Japan as a result of new ethical review requirements that take effect today.

Since embryonic stem cells can differentiate into any type of tissue, they have the potential to treat an almost unending array of medical conditions — replacing damaged or lost body parts or tissues, slowing degenerative diseases, even growing new organs.

Last January, the House of Representatives voted, 253 to 174, to pass a bill, H.R. 3, that would allow researchers to use leftover embryos from in vitro fertilization (IVF) clinics to create new lines of embryonic stem cells, and in April, the Senate passed its version of the bill.

Because biologists like Daley are convinced that embryonic stem cells — the most generic, versatile type — may not only lead to dramatically different new treatments but can also uniquely illuminate the origins of disease in a way adult stem cells never will.

The new approach builds on information gleaned from developmental studies of embryonic stem cells (see story # 16) and one day may be used to create healthy replacements for harmed or diseased tissue.

When he injected mice with embryonic stem cells genetically identical to the mice's own tissues, the new cells thrived, growing into a large clump of adult tissues.

The world's first chimeric monkeys were created in a laboratory last year, and they offer surprising new insights into embryonic stem cell therapy: One reason for often - poor treatment outcomes may be that we're using embryos that are, strangely, just too old.

- Our results provide new insights into the mechanisms of how POLR3G gene regulates stem cell state, which in turn sheds light on the complex mechanisms with which human embryonic stem cells both self - renew and maintain the ability to differentiate.

In another surprise, NIH located two embryonic stem cell groups in India: one at Reliance Life Sciences in Mumbai, which makes new blood products; the other at the National Center for Biological Sciences in Bangalore.

«New tools to study the origin of embryonic stem cells.»

Researchers from Turku, Finland, have discovered new information about the mechanisms which maintain gene activity in human embryonic stem cells.

All the potential of embryonic stem cells might be harnessed with the new techniques — without the political and moral controversy associated with destroying a fertilized egg.

Salk scientists and colleagues have proposed new molecular criteria for judging just how close any line of laboratory - generated stem cells comes to mimicking embryonic cells seen in the very earliest stages of human development, known as naïve stem cells.

Scientists have suggested that such embryonic stem cells could be used for learning about genetic diseases, testing new drugs on cells grown in the lab, or growing healthy cells for therapeutic transplantation.

One is using cells derived from human embryonic stem cells to treat spinal cord injury (although funding problems have stopped the trial enrolling new patients) and another is testing a treatment for age - related macular degeneration.

After two earlier published attempts that led to early - stage embryos but not confirmed embryonic stem cells, Mitalipov and colleagues took steps to preserve a protein complex believed to help primate eggs restructure transplanted DNA, and employed a new imaging system to observe the egg's chromosomes directly instead of by staining them or using ultraviolet light, which might damage DNA.

A new study in Nature Genetics identifies a specific population of pluripotent embryonic stem cells that can reprogram to totipotent - like cells in culture.

The new finding brings a measure of closure to a story that first rocked the science world in February 2004, when Hwang and colleagues at Seoul National University announced they had cloned a female donor's cell by transferring its nucleus into one of her egg cells stripped of its nucleus in a procedure known as somatic cell nuclear transfer (SCNT), and harvested embryonic stem cells from the resulting fusion.

A new paper in the journal Cell claiming to have achieved breakthrough stem cell work — using cloning to create personalized human embryonic stem cells — is coming under serious scrutiny.

Now, a new paper suggests that mouse embryonic stem cells can indeed accomplish this feat and lead to a partial recovery for animals with brain damage akin to Parkinson's.

Several researchers are now using cloning techniques to produce embryonic stem cells, thereby avoiding the need to collect new embryos.

A bill that would allow federal funding for derivation of new lines of human embryonic stem (ES) cells passed the U.S. House of Representatives yesterday 238 to 194 after more than four hours of debate.

Research involving human embryonic stem cells will become easier in Japan as a result of new ethical review requirements that took effect 21 August.

Teitelbaum says the new Democrat majority in the U.S. House could bolster efforts to expand federal funding of embryonic stem cell research beyond the limits that President George W. Bush laid down in 2001.

According to a new analysis, the cell line they created represented the first example of parthenogenetic human embryonic stem (ES) cells.

As described in the journal Genes & Development, the researchers identified a new pathway controlling heterochromatin organisation in mouse embryonic stem cells.

New study shows that adult skin cells made to differentiate like embryonic stem cells may reverse neurological damage

However, it would be unwise to ignore the potential for either adult or embryonic stem cells to result in a meaningful new approach.

The first clinical trial using embryonic stem cells to treat paralysis was approved by the Food and Drug Administration even before the new order.

This insight provides new avenues for improving the quality and stability of embryonic stem cells — an essential requirement to fulfil their promise in regenerative medicine.

Research led by the Babraham Institute with collaborators in the UK, Canada and Japan has revealed a new understanding of how an open genome structure supports the long - term and unrestricted developmental potential in embryonic stem cells.

Adult and embryonic stem cells are complementary subjects of research and studying them side by side offers the greatest potential to rapidly generate new therapies.